Dr. Jun Bao, President & CEO
Dr. Jun Bao, President & CEO, with more than 20 years of comprehensive experience in the production and research, extensive experience in drug research and development, technology transfer, licensing and business development, venture investment, entrepreneurship and corporate finance. Before IMPACT Therapeutics, he was SVP & CBO at Shenogen Pharma. He also worked as Director of corporate development and financial planning in Onyx followed by Director of Worldwide BD & Head of China BD in GSK. Moreover, in Seattle, he worked at ICOS Corporation and Cell Therapeutics as a business development executive with progressive responsibilities.
Dr. Ye Edward Tian, Executive Vice President & Chief Scientific Officer
Dr. Ye Edward Tian, EVP & CSO, came from Transtech Pharma in High Point, NC with 20 years of drug discovery experience. Served as Research Fellow and Associate Director, Dr. Tian played critical roles in several drug discovery projects that have advanced to clinical trials. Prior to that, he was a Senior Scientist at Pfizer in Ann Arbor, MI. Dr. Tian received his PhD in Neuroscience and Pharmacology from Michigan State University.
Dr. Sui Xiong Cai, Executive Vice President & Chief Technical Officer
Dr. Sui Xiong Cai, EVP & CTO, joined the company from San Diego, CA with more than 20 years of drug discovery experience. Served as Senior Director of Chemistry at EpiCept, Maxim Pharmaceuticals and Cytovia Inc., Dr. Cai played critical roles in several anticancer projects that have resulted in two drugs in Phase II clinical trials. He is an inventor of more than 90 issued patents and he received his PhD in Organic Chemistry from University of Oregon.
Dr. Cong Xu, Vice President，Medical，China
Dr. Cong Xu has more than 10 years experience in pre/clinical research and medical affairs in oncology. He led new drug development across various tumor indications including breast, ovarian, lung caner at Eli Lilly when he was an associate medical director. His work covered clinical strategy to operation, as well as medical affairs for on market products. Dr. Xu has undergraduate degree in Medicine from Tongji Medical College, PhD in Biology from Clemson University and MBA from UBC.